Last reviewed · How we verify
NCT05047003: RESTLESS
Oculogica Portable EyeBOX Study
trial testing EyeBOX Model EBX-4 (Portable version) in Concussion, Brain in 100 participants. Completed in 1 October 2022.
1 September 2022
Quick facts
| Lead sponsor | Oculogica, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 19 December 2020 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 October 2022 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- EyeBOX Model EBX-4 (Portable version)
Conditions studied
- Concussion, Brain — all drugs for Concussion, Brain →
- Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →
Sponsor
Oculogica, Inc.
Who can join
Adults 5 to 67, any sex, with Concussion, Brain or Mild Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to assess the accuracy of a portable version of the EyeBOX device, an eye-tracking based diagnostic, in comparison to a clinical reference standard of concussion. The utility of the portable assessment to aid in the monitoring of symptoms over time after an initial diagnosis of concussion will also be evaluated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05047003
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Concussion, Brain
Currently open trials in the same condition.
- NCT06956417 — REhabilitation of MEMory Symptoms After BRain Concussion · NA · recruiting
- NCT06739785 — Turkish Translation of SportsConcussion Assesment Tool 6 · active not recruiting
- NCT06270290 — The COSP-RBD Study: Concussions and Contact Sports in RBD vs Controls · recruiting
- NCT06208813 — Creatine Supplementation in Concussion Recovery · NA · recruiting
- NCT06036147 — Concussion Health Improvement Program · NA · recruiting
Other Oculogica, Inc. trials
Trials by the same sponsor.
- NCT05527041 — A Highly Portable Device for Assessment of Mild Traumatic Brain Injury in Deployed and Far-Forward Settings · enrolling by invitation
- NCT04799093 — Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication · completed
- NCT03966404 — EyeBOX Concussion Study and Registry · completed
- NCT03418753 — Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05047003 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oculogica, Inc.
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05047003.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing